Dianthus Therapeutics (DNTH) EBT Margin (2022 - 2025)
Dianthus Therapeutics (DNTH) reported EBT Margin of -9250.00% for Q3 2025, down 8078.04 percentage points from -1171.96% a year earlier but up 7083.68 percentage points from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) EBT Margin (2022 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Dianthus Therapeutics' EBT Margin came in at -4076.22%, down 2826.03 percentage points year-over-year; for FY2024, it was -1355.24%, up 180.86 percentage points from FY2023.
- By year, EBT Margin came in at -1536.09% in FY2023 (-1313.26 pp) and -222.83% in FY2022.
- Five-year quarterly EBT Margin spans a low of -16333.68% in Q2 2025 and a high of -132.71% in Q4 2022.
- Year over year, EBT Margin has now declined in each of the last three quarters, with an average year-over-year change of -3400.14 percentage points over the last eight quarters.
- The high point for year-over-year EBT Margin in five years was Q3 2024 (a gain of 422.41 percentage points); the low point was Q2 2025 (a drop of 15394.55 percentage points).
- Per Business Quant data, the three quarters before Q3 2025 came in at -16333.68% (Q2 2025), -2526.74% (Q1 2025) and -2106.03% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Dianthus Therapeutics | 3.76 Bn | 3.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -9,250.00% |
| Jun 30, 2025 | -16,333.68% |
| Mar 31, 2025 | -2,526.74% |
| Dec 31, 2024 | -2,106.03% |
| Sep 30, 2024 | -1,171.96% |
| Jun 30, 2024 | -939.13% |
| Mar 31, 2024 | -1,558.58% |
| Dec 31, 2023 | -2,300.22% |
| Sep 30, 2023 | -1,594.37% |
| Jun 30, 2023 | -563.18% |
| Mar 31, 2023 | -725.10% |
| Dec 31, 2022 | -132.71% |
| Sep 30, 2022 | -668.20% |
API Access
Dianthus Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();